NCT06388668 Lipid Testing After Myocardial Infarction at the Montreal Heart Institute
| NCT ID | NCT06388668 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montreal Heart Institute |
| Condition | Dyslipidemias |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-06-01 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization. It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute. Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission. Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.
Eligibility Criteria
Inclusion Criteria: * Adult patients ≥18 years old * Hospitalized at the Cardiac Care Unit for Myocardial Infarction (either NSTEMI or STEMI) * Lipid panel performed on day 0 of admission * Willing to provide informed consent Exclusion Criteria: * None
Contact & Investigator
Guillaume Marquis-Gravel, MD, MSc
PRINCIPAL INVESTIGATOR
Montreal Heart Institute
Frequently Asked Questions
Who can join the NCT06388668 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dyslipidemias. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06388668 currently recruiting?
Yes, NCT06388668 is actively recruiting participants. Contact the research team at suzy.otis@icm-mhi.org for enrollment information.
Where is the NCT06388668 trial being conducted?
This trial is being conducted at Montreal, Canada, Montreal, Canada.
Who is sponsoring the NCT06388668 clinical trial?
NCT06388668 is sponsored by Montreal Heart Institute. The principal investigator is Guillaume Marquis-Gravel, MD, MSc at Montreal Heart Institute. The trial plans to enroll 100 participants.